688319 欧林生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.0392.2541.9523.07917.675
总资产报酬率 ROA (%)2.5311.2141.1361.97511.652
投入资产回报率 ROIC (%)3.5591.6931.6022.76316.560

边际利润分析
销售毛利率 (%)93.09794.44693.55092.86593.927
营业利润率 (%)10.9693.6190.6257.60120.852
息税前利润/营业总收入 (%)13.0775.4884.0918.21221.991
净利润/营业总收入 (%)9.3012.6702.3064.85422.162

收益指标分析
经营活动净收益/利润总额(%)119.56184.56733.73167.60994.906
价值变动净收益/利润总额(%)0.4653.8366.6718.4783.512
营业外收支净额/利润总额(%)0.2604.45480.1594.6565.231

偿债能力分析
流动比率 (X)1.5251.5251.9551.7822.561
速动比率 (X)1.4161.3811.8041.6322.343
资产负债率 (%)50.21348.34142.28239.69430.302
带息债务/全部投入资本 (%)26.38926.11518.65811.3032.665
股东权益/带息债务 (%)263.846274.486422.883757.4133,545.245
股东权益/负债合计 (%)98.281105.854134.475150.186230.013
利息保障倍数 (X)6.2893.2274.33534.304-1,787.579

营运能力分析
应收账款周转天数 (天)327.922323.304356.438272.293194.981
存货周转天数 (天)595.981868.416847.387705.108733.200